Clinical trial
Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic…
NCT00003437 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00003437 |
|---|---|
| Title | Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia |
| Official title | Medical Research Council Working Party on Leukaemia in Children UK National Lymphoblastic Leukaemia (ALL) Trial |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, mercaptopurine, methotrexate, pegaspargase, prednisolone and 3 more |
| Enrollment | 1,800 |
| Start date | Jan 1, 1997 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 4, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: